Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of D-2570 in Active Systemic Lupus Erythematosus
NCT07311200Phase 2Recruiting
- Sponsor
- InventisBio
- Start
- Feb 2026
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D-2570 in systemic lupus erythematosus (SLE), sponsored by InventisBio. Started Feb 2026; status: recruiting.
02
Drugs
D-2570
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07311200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311200.